Sun Pharma Q4 Results: Profit Tumbles On Litigation Costs, Revenue Rises
Pills arranged for a photograph in Tokyo, Japan. (Photographer: Kiyoshi Ota/Bloomberg)

Sun Pharma Q4 Results: Profit Tumbles On Litigation Costs, Revenue Rises

Drugmaker Sun Pharmaceutical Industries Ltd.’s quarterly profit fell as a one-time litigation cost offset the sales benefit from new launches.Net profit fell 42% year-on-year to Rs 400 crore in the...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.